Bone marrow stem cell therapy for cardiac repair: Challenges and perspectives

Minerva Cardioangiologica

Volumn 55, Issue 5, 2007, Pages 659-667

  Vassalli, G ^a   Vanderheyden, M ^b   Renders, F ^a,b   Eeckhout, E ^a   Bartunek, J ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b CARDIOVASCULAR CENTER   (Belgium)

Author keywords

Bone marrow; Myocardial infarction; Stem cells; Tissue therapy

Indexed keywords

ACUTE HEART INFARCTION; CELL HOMING; CELL POPULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; TREATMENT OUTCOME;

EID: 36749000510     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Forbes SJ, Vig P, Poulsom R, Wright NA, Alison MR. Adult stem cell plasticity: new pathways of tissue regeneration become visible. Clin Sci 2002;103:355-69.
2. Eisenberg LM, Burns L, Eisenberg CA. Hematopoietic cells from bone marrow have the potential to differentiate into cardiomyocytes in vitro. Anat Rec A Discov Mol Cell Evol Biol 2003;274:870-82.
3. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
4. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-402.
5. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005;96:127-37.
6. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-8.
7. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, Fernandez ME, Penarrubia MJ, de la Fuente L et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004;95:742-8.
8. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOP-CARE-AMI Trial. J Am Coll Cardiol 2004;44:1690-9.
9. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005;112(9 Suppl):I178-83.
10. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-8.
11. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006;113:1287-94.
12. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-209.
13. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367:113-21.
14. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H et al.; REPAIR-AMI Investigators. Intracoronary bone manow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21.
15. Rolf A, Dill T, Moellmann S, Conradi G, Schaechinger V et al. One year follow-up of left ventricular function and remodeling after intracoronary infusion of bone marrow-derived progenitor cells after acute Stemi: MRI substudy of the double-blind, randomized, placebo-controlled multicenter Repair-AMI trial. J Am Coll Cardiol 2007;49(Suppl 2):22B-910-214.
16. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H et al.; REPAIR-AMI Investigators. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006;27:2775-83.
17. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-5.
18. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-6.
19. Kang HJ, Lee HY, Na SH, Chang SA, Park KW, Kim HK et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006;114(1 Suppl):I145-51.
20. Kuci S, Wessels JT, Buhring HJ, Schilbach K, Schumm M, Seitz G et al. Identification of a novel class of human adherent CD34-stem cells that give rise to SCID-repopulating cells. Blood 2003;101:869-76.
21. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6.
22. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-302.
23. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361:47-9.
24. Li TS, Hamano K, Hirata K, Kobayashi T, Nishida M. The safety and feasibility of the local implantation of autologous bone marrow cells for ischemic heart disease. J Card Surg 2003;8 Suppl 2:S69-75.
25. Galinanes M, Loubani M, Davies J, Chin D, Pasi J, Bell PR. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 2004;1:7-13.
26. Katritsis DG, Sotiropoulou PA, Karvouni E, Karabinos I, Korovesis S, Perez SA et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 2005;65:321-9.
27. Ozbaran M, Omay SB, Nalbantgil S, Kultursay H, Kumanlioglu K, Nart D et al. Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. Eur J Cardiothorac Surg 2004;25:342-50; discussion 350-1.
28. Boyle AJ, Whitbourn R, Schlicht S, Krum H, Kocher A, Nandurkar H et al. Intracoronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol 2006;109:21-7.
29. Pompilio G, Cannata A, Peccatori F, Bertolini F, Nascimbene A, Capogrossi MC et al. Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg 2004;78:1808-12.
30. Fuchs S, Kornowski R, Weisz G, Satler LF, Smits PC, Okubagzi P et al. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol 2006;97:823-9.
31. Strauer BE, Brehm M, Zeus T, Bartsch T, Schannwell C, Antke C et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 2005;46:1651-8.
32. Erbs S, Linke A, Adams V, Lenk K, Thiele H, Diederich KW et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 2005;97:756-62.
33. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32.
34. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC Jr, Kormos R et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005;130:1031-8.
35. Bryder D, Rossi DJ, Weissman IL. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 2006;169:338-46. Erratum in: Am J Pathol 2006;169:1899.
36. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004;95:9-20.
37. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9.
38. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005;115:326-38.
39. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of post-natal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004;117:2971-81.
40. Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133:717-25.
41. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 2001;7:259-64. 42. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-22.
42. Makkar RR, Price MJ, Lill M, Frantzen M, Takizawa K, Kleisli T et al. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther 2005;10:225-33.
43. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005;112:214-23.
44. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004;363:783-4.
45. Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 2007;28:766-72.
46. Zhang H, Fazel S, Tian H, Mickle DAG, Weisel RD, Fujii T et al. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am J Physiol Heart Circ Physiol 2005;289:H2089-96.
47. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109:1615-22.
48. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005;111:2198-202.
49. Penicka M, Lang O, Widimsky P, Kobylka P, Kozak T, Vanek T et al. One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction. Heart 2007;93:837-41.
50. Bartunek J, Wijns W, Heyndrickx GR, Vanderheyden M. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nat Clin Pract Cardiovasc Med 2006;3(Suppl 1):S52-6.
51. Bartunek J, Dimmeler S, Drexler H, Fernandez-Aviles F, Galinanes M, Janssens S et al.; task force of the European Society of Cardiology. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 2006;27:1338-40.